References

Inflammatory bowel disease

10.1056/nejmra0804647 · 2009 · External reference

The four epidemiological stages in the global evolution of inflammatory bowel disease

10.1038/s41575-020-00360-x · 2021 · External reference

Evolution of inflammatory bowel disease in Korea: a 60-year perspective on clinical and research development

10.5217/ir.2025.00073 · 2025 · External reference

Mechanisms of disease: inflammatory bowel diseases

10.1016/j.mayocp.2018.09.013 · 2019 · External reference

Environmental and microbial factors in inflammatory bowel disease model establishment: a review partly through Mendelian randomization

10.5009/gnl230179 · 2024 · External reference

Inflammatory bowel diseases (IBD) and the microbiome—searching the crime scene for clues

10.1053/j.gastro.2020.09.056 · 2021 · External reference

Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease

10.5217/ir.2023.00080 · 2024 · External reference

Ecology of bacteria in the human gastrointestinal tract—identification of keystone and foundation taxa

10.1186/s40168-015-0107-4 · 2015 · External reference

Immunomodulating activity and therapeutic effects of short chain fatty acids and tryptophan post-biotics in inflammatory bowel disease

10.3389/fimmu.2019.02754 · 2019 · External reference

Enterotypes in the landscape of gut microbial community composition

10.1038/s41564-017-0072-8 · 2018 · External reference

Enterotype-based analysis of gut microbiota along the conventional adenoma-carcinoma colorectal cancer pathway

10.1038/s41598-019-45588-z · 2019 · External reference

Enterotype Bacteroides is associated with a high risk in patients with diabetes: a pilot study

10.1155/2020/6047145 · 2020 · External reference

The impact of gut microbiome enterotypes on ulcerative colitis: identifying key bacterial species and revealing species co-occurrence networks using machine learning

10.1080/19490976.2023.2292254 · 2024 · External reference

Gut microbiota analysis for prediction of clinical relapse in Crohn’s disease

10.1038/s41598-022-23757-x · 2022 · External reference

Gut microbiome structure and association with host factors in a Korean population

10.1128/msystems.00179-21 · 2021 · External reference

Age determines the risk of familial inflammatory bowel disease-a nationwide study

10.1111/apt.16938 · 2022 · External reference

Increased intestinal permeability in patients with Crohn’s disease and their relatives. A possible etiologic factor

10.7326/0003-4819-105-6-883 · 1986 · External reference

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families

10.1097/00054725-200102000-00002 · 2001 · External reference

Intestinal permeability in patients with Crohn’s disease and ulcerative colitis and their first degree relatives

10.1136/gut.35.1.68 · 1994 · External reference

Healthy first-degree relatives from multiplex families vs simplex families have higher subclinical intestinal inflammation, a distinct fecal microbial signature, and harbor a higher risk of developing Crohn’s Disease

10.1053/j.gastro.2024.08.031 · 2025 · External reference

Anti-microbial antibody response is associated with future onset of Crohn’s disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk

10.1053/j.gastro.2021.07.009 · 2021 · External reference

Fecal fungal microbiota (mycobiome) study as a potential tool for precision medicine in inflammatory bowel disease

10.5009/gnl220537 · 2023 · External reference

Characteristics associated with the occurrence and development of acute anterior uveitis, inflammatory bowel disease, and psoriasis in patients with ankylosing spondylitis: data from the Chinese Ankylosing Spondylitis Prospective Imaging Cohort

10.1007/s40744-021-00293-0 · 2021 · External reference

Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease

10.5217/ir.2022.00057 · 2023 · External reference

The genetics of inflammatory bowel disease

10.1007/s40291-023-00678-7 · 2024 · External reference

The causal relationship between psoriasis, psoriatic arthritis, and inflammatory bowel diseases

10.1038/s41598-022-24872-5 · 2022 · External reference

Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011

10.1038/ajg.2015.50 · 2015 · External reference

Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach

10.1038/s41598-020-67710-2 · 2020 · External reference

Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2

10.1038/s41587-019-0209-9 · 2019 · External reference

Cutadapt removes adapter sequences from high-throughput sequencing reads

10.14806/ej.17.1.200 · 2011 · External reference

DADA2: High-resolution sample inference from Illumina amplicon data

10.1038/nmeth.3869 · 2016 · External reference

A complete domain-to-species taxonomy for Bacteria and Archaea

10.1038/s41587-020-0501-8 · 2020 · External reference

Scikit-learn: machine learning in Python

2011 · External reference

PICRUSt2 for prediction of metagenome functions

10.1038/s41587-020-0548-6 · 2020 · External reference

FastSpar: rapid and scalable correlation estimation for compositional data

10.1093/bioinformatics/bty734 · 2019 · External reference

Cytoscape: a software environment for integrated models of biomolecular interaction networks

10.1101/gr.1239303 · 2003 · External reference

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model

10.1186/s12866-015-0400-1 · 2015 · External reference

Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis

10.3748/wjg.v20.i41.15163 · 2014 · External reference

Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease

10.1128/jcm.01500-13 · 2014 · External reference

Deciphering gut microbiome patterns from host preferences and microbial interactions in healthy Korean individuals

10.1186/s12915-025-02291-y · 2025 · External reference

Formation of propionate and butyrate by the human colonic microbiota

10.1111/1462-2920.13589 · 2017 · External reference

The genus Alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health

10.3389/fimmu.2020.00906 · 2020 · External reference

Comparative in silico analysis of butyrate production pathways in gut commensals and pathogens

10.3389/fmicb.2016.01945 · 2016 · External reference

Adlercreutzia faecimuris sp. nov., producing propionate and acetate isolated from mouse feces

10.1007/s10482-024-01980-y · 2024 · External reference

The rheumatoid arthritis gut microbial biobank reveals core microbial species that associate and effect on host inflammation and autoimmune responses

10.1002/imt2.242 · 2024 · External reference

Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product

10.1128/aem.70.10.5810-5817.2004 · 2004 · External reference

Lacticaseibacillus casei IB1 alleviates DSS-induced inflammatory bowel disease by regulating the microbiota and restoring the intestinal epithelial barrier

10.3390/microorganisms12071379 · 2024 · External reference

Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation

10.1053/j.gastro.2011.05.035 · 2011 · External reference

The enterococcus: a model of adaptability to its environment

10.1128/cmr.00058-18 · 2019 · External reference

Microbiota disbiosis is associated with colorectal cancer

10.3389/fmicb.2015.00020 · 2015 · External reference

Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer

10.1038/s41598-021-82465-0 · 2021 · External reference

Role of vitamin K in intestinal health

10.3389/fimmu.2021.791565 · 2021 · External reference

Control of the innate immune response by the mevalonate pathway

10.1038/ni.3487 · 2016 · External reference

Novel mechanism of beta-lactam resistance due to bypass of DD-transpeptidation in Enterococcus faecium

10.1074/jbc.m909877199 · 2000 · External reference

Murimonas intestini gen. nov., sp. nov., an acetate-producing bacterium of the family Lachnospiraceae isolated from the mouse gut

10.1099/ijs.0.000030 · 2015 · External reference

Acetatifactor muris gen. nov., sp. nov., a novel bacterium isolated from the intestine of an obese mouse

10.1007/s00203-012-0822-1 · 2012 · External reference

Unravelling lactate-acetate and sugar conversion into butyrate by intestinal Anaerobutyricum and Anaerostipes species by comparative proteogenomics

10.1111/1462-2920.15269 · 2020 · External reference

Coprococcus eutactus, a potent probiotic, alleviates colitis via acetate-mediated IgA response and microbiota restoration

10.1021/acs.jafc.2c06697 · 2023 · External reference

Butyrate-producing bacteria supplemented in vitro to Crohn’s disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity

10.1038/s41598-017-11734-8 · 2017 · External reference

A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients

10.1186/s13073-017-0490-5 · 2017 · External reference

Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review

10.1053/j.gastro.2019.11.294 · 2020 · External reference

Disease severity and immune activity relate to distinct interkingdom gut microbiome states in ethnically distinct ulcerative colitis patients

10.1128/mbio.01072-16 · 2016 · External reference